entertainment -WSS

entertainment

author：hotspot 2025-10-02 19:15:21 - browse：4

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： What Congress can do to address the rural doctor shortage

WSS

Biotech stock slump in 2023: awaiting the turnaround

Slain Parkland victim's father speaks out following reenactment

Hearing on Medicare drug price negotiation gets unusually heated

Does Medicare's free annual wellness visit do any good?

New company forms to vet health AI models, root out weaknesses

It's been 20 years since Dolly the sheep. Where's my clone?

knowledge

entertainment

entertainment

Apple is now the first public company to be valued at $3 trillion

CommonSpirit Health keeps growing, even as it loses money

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How AI helped researchers track recovery from depression

DIEP, the 'gold standard' of breast reconstruction, is under threat

CommonSpirit Health keeps growing, even as it loses money

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Climate activists disrupt London Pride march to protest corporate sponsorship

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CDC's new outbreak response network to include Northeastern

focus

Readout LOUD podcast: possible new ALS drug, artificial wombs

Biotech lab space demand falls sharply

How Vertex's cystic fibrosis drug is changing patients' lives

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Drug for rare kidney disease narrowly misses mark in clinical trial

Does Medicare's free annual wellness visit do any good?

explore

explore

entertainment

hotspot